Actelion obtains option to acquire privately-held Trophos
21-Jul-2010 -
Actelion Ltd and privately-held Trophos SA announced that they have entered into a binding agreement whereby Actelion has, for EUR 10 million, obtained an exclusive option to acquire privately-held Trophos SA, a clinical stage pharmaceutical company.
Trophos' lead compound olesoxime has ...
Actelion
amyotrophic lateral sclerosis
business development
+4